Abeona Therapeutics (ABEO) Interest Income - Total (2021 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Interest Income - Total of $1.4 million for Q1 2026, up 3.36% year-over-year from $1.3 million in Q1 2025, and down 12.48% quarter-over-quarter from $1.5 million in Q4 2025.
Abeona Therapeutics (ABEO) Interest Income - Total (2021 - 2026) Analysis & Trends
Abeona Therapeutics' Interest Income - Total history runs 6 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- In Q1 2026, Interest Income - Total rose 3.36% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $5.6 million (up 18.82% YoY), while the FY2025 annual figure was $5.6 million, up 30.85% from the prior year.
- Interest Income - Total for Q1 2026 stood at $1.4 million, down from $1.5 million in the prior quarter.
- The five-year high for Interest Income - Total was $1.7 million in Q3 2025, with the low at $7000.0 in Q1 2022.
- The 5-year median for Interest Income - Total is $843000.0 (2024), against an average of $806529.4.
- The sharpest annual moves came in 2022 and 2025: Interest Income - Total surged 6460.0% in 2022, then declined 13.77% in 2025.
- Abeona Therapeutics' Interest Income - Total stood at $328000.0 in 2022, then jumped by 126.52% to $743000.0 in 2023, then jumped by 37.69% to $1.0 million in 2024, then jumped by 51.22% to $1.5 million in 2025, then retreated by 12.48% to $1.4 million in 2026.
- Business Quant data shows ABEO's Interest Income - Total at $1.4 million in Q1 2026, $1.5 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Total (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Abeona Therapeutics | 342.78 Mn | 195.96 Mn | 7.20 Mn | 1.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.36 Mn |
| Jun 30, 2026 | 1.36 Mn |
| Mar 31, 2026 | 1.35 Mn |
| Mar 31, 2026 | 1.35 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | 1.67 Mn |
| Sep 30, 2025 | 1.67 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.31 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 843,000.00 |
| Mar 31, 2024 | 843,000.00 |